Filgrastim Recruiting Phase 2 Trials for Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 / Myelodysplastic Syndrome With Excess Blasts / Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 / Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 / t(16;16) / Acute Myelogenous Leukaemia (AML) / Inv(16) / High Risk Myelodysplastic Syndrome / T(8;21) / Untreated Adult Acute Myeloid Leukemia / de Novo Myelodysplastic Syndrome Treatment